Previous 10 | Next 10 |
Looking to catch lightning in a bottle? Penny stocks can be your hot ticket. But in today’s article, we’re not talking about safety first, we’re talking about high-risk, volatile trading. One of the most frequently discussed topics this year is short squeeze stocks. ...
LPTX has shown that it can surge on positive data. The trial from which this data came will be completed by year-end. I expect another small spike around that time. For further details see: Leap Therapeutics: Another Leap Coming Up
Leap Therapeutics is an early stage oncology company with a single active asset. Their single asset focuses on a pathway that is dysregulated in multiple cancers. Early data is a mixed bag, with potential efficacy seen in gastric cancer. Investing in Leap Therapeutics can be c...
The biotech industry continues to play a crucial role in developing solutions to treat critical ailments. In addition, the demand for biotech solutions is also high across other sectors such as food and agriculture. So, biotech stocks such as Leap Therapeutics (LPTX) and Corvus Pharmaceutical...
The following slide deck was published by Leap Therapeutics, Inc. in conjunction with this event. For further details see: Leap Therapeutics (LPTX) ESMO 2021Virtual Congress Presentation - Slideshow
Leap Therapeutics Announces Closing of Public Offering of Common Stock and Pre-Funded Warrants and Full Exercise of Underwriters' Option to Purchase Additional Shares PR Newswire CAMBRIDGE, Mass. , Sept. 24, 2021 /PRNewswire/ -- Leap Therapeutics, Inc. (Nasd...
Leap Therapeutics Inc. (NASDAQ:LPTX) traded today at a new 52-week high of $3.75. Approximately 9.7 million shares have changed hands today, as compared to an average 30-day volume of 8.3 million shares. Potential upside of 79.7% exists for Leap Therapeutics Inc., based on a current leve...
Leap Therapeutics Announces Pricing of $90 million of Common Stock and Pre-Funded Warrants PR Newswire CAMBRIDGE, Mass. , Sept. 22, 2021 /PRNewswire/ -- Leap Therapeutics, Inc. (Nasdaq:LPTX), a biotechnology company focused on developing targeted and immuno-...
3 Tips For Investing in Penny Stocks in a Down Market When the stock market is down, it presents a sizable number of opportunities for penny stock investors to capitalize on. But, it takes understanding why the market is down to do so. With penny stocks , there are several differenc...
Listen on the go! A daily podcast of Wall Street Breakfast's Alpha Talks will be available this morning on Seeking Alpha, iTunes, Stitcher and Spotify. Stocks touched their lowest levels in four weeks Friday as inflation fears took hold and a range of Chinese economic indicators pointed to a ...
News, Short Squeeze, Breakout and More Instantly...
Leap Therapeutics Inc. Company Name:
LPTX Stock Symbol:
NASDAQ Market:
Leap Therapeutics Inc. Website:
Leap Therapeutics Reports First Quarter 2024 Financial Results PR Newswire CAMBRIDGE, Mass. , May 13, 2024 /PRNewswire/ -- Leap Therapeutics, Inc. (Nasdaq:LPTX), a biotechnology company focused on developing targeted and immuno-oncology therapeutics, today report...
Leap Therapeutics Announces $40 Million Private Placement PR Newswire Net proceeds, along with existing cash, cash equivalents, and marketable securities are expected to extend cash runway into Q2 2026 and enable expansion of DKN-01 DeFianCe clinical trial and development prog...
Leap Therapeutics Reports Fourth Quarter and Full Year 2023 Financial Results PR Newswire CAMBRIDGE, Mass. , March 18, 2024 /PRNewswire/ -- Leap Therapeutics, Inc. (Nasdaq:LPTX), a biotechnology company focused on developing targeted and immuno-oncology therapeut...